Key result
Intravenous infusion of sympathomimetic compounds raised plasma free fatty acid levels, an effect correlated with Beta-adrenergic circulatory effects and abolished by propranolol pretreatment.
Why the study?
Do intravenously infused sympathomimetic compounds with beta-adrenergic effects raise plasma free fatty acids in humans?
Do intravenously infused sympathomimetic compounds with beta-adrenergic effects raise plasma free fatty acids in humans?
Sympathomimetic compounds that stimulate beta-receptors acutely raise plasma free fatty acid concentrations in humans.
Answers are grounded in this paper and cite their sources.
Acute beta-agonists may raise free fatty acids; leaves open relevance to chronic use or outcomes.
Nine sympathomimetic compounds were infused intravenously in man, and their effects on the level of plasma free fatty acids, pulse rate, and blood pressure were recorded. Each compound raised the level of plasma free fatty acids. Its activity in this respect could be correlated with its activity in producing Beta-adrenergic effects on the circulation; both effects were abolished by pretreatment with propranolol. It is concluded that sympathomimetic compounds that stimulate -receptors will raise the plasma concentration of free fatty acids.
No takes yet. Share an insight, caveat, or question.
Pilkington et al. (1966) studied this question. Sympathomimetic compounds vs. Pretreatment with propranolol was evaluated on Plasma free fatty acids. Intravenous infusion of sympathomimetic compounds raised plasma free fatty acid levels, an effect correlated with Beta-adrenergic circulatory effects and abolished by propranolol pretreatment.
Synapse has enriched 10 related papers. Consider them for comparative context: